News
AOP Orphan Statement on SARS-CoV-2 and COVID-19
17. 3. 2020AOP Orphan hosted an Experts Press Conference at DGHO in Berlin
7. 10. 2019AOP Orphan hosted Industry Symposium at DGHO in Berlin
7. 10. 2019
Meet Us Globally
- 8Jun.
Bio Digital 2020
SAN DIEGO, US - 10Jun.
Virtual Congress
EHA 2020FRANKFURT, GERMANY - 2Jul.
PH Academy
VIENNA , AUSTRIA
From the Concept to the Drug
AOP Orphan team covers all essential aspects of product development, starting with preclinical research & toxicology, extending to pharmaceutical & clinical development, including regulatory affairs, quality management & pharmacovigilance.
Partnering
Partnering is of key importance for AOP Orphan. It allows further developing AOP Orphan’s rare disease portfolio and enables to approach patients beyond company’s core markets in Europe.
Join AOP Orphan
AOP Orphan team develops and investigates therapy options for patients with rare diseases – commitment and appreciation are the essence of our cooperative work.